Back to search

Sweden· SE-20201203000024

Mykofenolsyra Medartuum 180 mg Enterotablett

A medicinal product, registered in Sweden by Medartuum AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedMykofenolsyra Medartuum 180 mg Entero…ATC—REGISTER NO.SE-20201203000024PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
Medartuum AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20201203000024

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdd51fe4-23cb-41c9-a67a-6738ace5e3eb
GET /v1/drugs/bdd51fe4-23cb-41c9-a67a-6738ace5e3eb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20201203000024",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20201203000024",
  "product_doc_link": "https://docetp.mpa.se/LMF/Mykofenolsyra%20Medartuum%20180%20mg%20360%20mg%20gastro-resistant%20tablet%20ES%20PL_09001bee81e76d96.pdf"
}

See everything about Mykofenolsyra.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.